499 related articles for article (PubMed ID: 12461329)
21. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
Park HW; Song SY; Lee TJ; Jeong D; Lee TY
Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
[TBL] [Abstract][Full Text] [Related]
22. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
[TBL] [Abstract][Full Text] [Related]
23. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
24. Tumours of familial origin in the head and neck.
Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
[TBL] [Abstract][Full Text] [Related]
25. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed AL; Califano J; Cairns P; Westra WH; Jones RM; Koch W; Ahrendt S; Eby Y; Sewell D; Nawroz H; Bartek J; Sidransky D
Cancer Res; 1996 Aug; 56(16):3630-3. PubMed ID: 8705996
[TBL] [Abstract][Full Text] [Related]
26. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
27. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
28. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
29. p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco JW; Li D; Liggett WH; Duan L; Saunders JK; Sidransky D; O'Malley BW
Clin Cancer Res; 1998 Jul; 4(7):1697-704. PubMed ID: 9676844
[TBL] [Abstract][Full Text] [Related]
30. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
31. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
Suominen E; Toivonen R; Grenman R; Savontaus M
J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
[TBL] [Abstract][Full Text] [Related]
32. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].
Soufir N; Basset-Seguin N
Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799
[TBL] [Abstract][Full Text] [Related]
33. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
34. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
35. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
[TBL] [Abstract][Full Text] [Related]
36. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
[TBL] [Abstract][Full Text] [Related]
37. p16 gene alterations in locally advanced squamous cell carcinoma of the head and neck.
Wang D; Grecula JC; Gahbauer RA; Schuller DE; Jatana KR; Biancamano JD; Lang JC
Oncol Rep; 2006 Mar; 15(3):661-5. PubMed ID: 16465427
[TBL] [Abstract][Full Text] [Related]
38. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.
Zhang SY; Klein-Szanto AJ; Sauter ER; Shafarenko M; Mitsunaga S; Nobori T; Carson DA; Ridge JA; Goodrow TL
Cancer Res; 1994 Oct; 54(19):5050-3. PubMed ID: 7923115
[TBL] [Abstract][Full Text] [Related]
39. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]